Repositorio Digital de la UPF
Publicación
Artículo científico (JournalArticle)
Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks
The integration of nanotechnology into healthcare has introduced Nanotechnology-Enabled Health Products (NHPs), promising revolutionary advancements in medical treatments and diagnostics. Despite their potential, the regulatory navigation for these products remains complex and often lagging, creating barriers to their clinical application. This review article focuses on dissecting the regulatory landscape for NHPs, particularly in the European Union and the United States, to identify applicable requirements and the main regulatory guidelines currently available for meeting regulatory expectations., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Industrial Doctorates Plan of the Department of Research and Universities of the Generalitat de Catalunya (Grant n° 202015). PRG acknowledges the Ministry of Science, Innovation and Universities (MICINN-AEI) (AEI-PID2022-140423NB-I00/AEI/10.13039/501100011033, CNS2023 - 143700) and the AGAUR (2021 SGR 00175 and 2021 PROD 00041) for financial support.
Proyecto:
ES / 3PE PID2022-140423NB-I00